Sankyo Articles
Japan stock market week to Nov 28
5 December 2005
Sankyo's 1st-qtr sales and earnings dip
22 August 2005
Stock Commentary - Tokyo
15 August 2005
Japan stock market week to August 8
15 August 2005
S-P licenses Sankyo's cardio drug in Latin territories
15 August 2005
Japan stock market week to July 25
1 August 2005
Japan stock market week to July 11
18 July 2005
Teva loses exclusivity on pravastatin, US FDA
18 July 2005
Japan stock market week to July 4
11 July 2005
Japan stock market week to June 27
4 July 2005
Sankyo shareholders support Daiichi merger
4 July 2005
Japan stock market week to June 6
13 June 2005
Japan stock market week to May 23
30 May 2005
Japan stock market week to May 9
16 May 2005
Japan stock market week to May 2
9 May 2005
Forest Labs' sales hit by Celexa competition
25 April 2005
MerLion and Sankyo sign drug R&D deal
22 April 2005
Japan's most-admired pharma companies: NPP survey
18 April 2005
Japan's second-tier drugmakers losing out
11 April 2005
Metabasis continues evaluation of CS-917
11 April 2005
Japan stock market week to March 28
4 April 2005
Japan stock market week to February 28
7 March 2005
Editor's views on Japanese M&A; Tysabri withdrawal
7 March 2005
Sankyo and Daiichi prepare to merge?
28 February 2005
Japan stock market week to February 21
28 February 2005
Japan stock market week to February 14
21 February 2005
Few changes foreseen in Japan drugmakers' rankings
31 January 2005
Japan stock market week to January 17
24 January 2005
Forest disappoints, despite 17% EPS hike
24 January 2005
Japan stock market week to January 10
17 January 2005
Sankyo and Metabasis' start CS-917 Ph IIb trial
17 January 2005
Tokyo pharma stocks - week to November 15
22 November 2004
US sales decline hits Santen results
22 November 2004
BioMimetic Pharma raises $25.7M
15 November 2004
Tokyo pharma stocks - week to November 1
8 November 2004
Exelixis to acquire X-Ceptor
4 October 2004
Generics battering Sankyo's home sales
4 October 2004
Tokyo pharma stocks - week to Sept 13
20 September 2004
Tokyo pharma stocks - week to September 6
13 September 2004
Lilly's CS-747 shows good safety profile
13 September 2004
Tokyo pharma stocks - 2 weeks to August 30
6 September 2004
Sankyo sales down but profits leap 60%
9 August 2004
Tokyo pharma stocks - week to August 2
9 August 2004
Tokyo pharma stocks - week to June 21
28 June 2004
Western drugmakers make inroads in Japan
28 June 2004
Foreigners up stakes in Japanese pharma companies
14 June 2004
Sankyo's full-year revenues rise 4.6%
7 June 2004
Tokyo pharma stocks - week to May 24
31 May 2004
Tokyo pharma stocks - week to April 26
3 May 2004
Tokyo pharma stocks - week to April 12
19 April 2004
Global peripheral neuropathy market worth $1B by 2012
19 April 2004
Japan announces 4.2% average Rx price cut
15 March 2004
Tokyo pharma stocks - week to March 8
15 March 2004
Tularik and Sankyo expand GPCR deal
15 March 2004
Tokyo pharma stocks - week to Feb 23
1 March 2004
Sankyo boosts full-year net forecast to 40B yen
23 February 2004
Tokyo pharma stocks - week to Feb 9
16 February 2004
Tokyo pharma stocks - week to Jan 26
2 February 2004
Sankyo's Mevalotin retains number one spot in Japan
2 February 2004
Kowa and Nikken to co-promote olmesartan medoxomil
2 February 2004
Daiwa Yakuhin to be acquired by Alfresa
2 February 2004
New Chemical Entities in 2003
19 January 2004
Sankyo and SSK to promote olmesartan
19 January 2004
Tokyo pharma stocks - week to Jan 12
19 January 2004
Appeals court rules for Pfizer
5 January 2004
Eisai's pravastatin generic sluggish
5 January 2004
Tokyo pharma stocks - week to Dec 15
22 December 2003
Aventis' Ketek launched in Japan
22 December 2003
Tularik and Sankyo advance GPCR drug discovery deal
22 December 2003
Tokyo pharma stocks - week to Dec 8
15 December 2003
Cyclacel in-licenses anticancer drug from Sankyo
15 December 2003
Stock Commentary - Tokyo
8 December 2003
Tokyo pharma stocks - week to Dec 1
8 December 2003
Sankyo hits forecasts, R&D spending delayed
24 November 2003
BTG acquires AD therapies from Sankyo
17 November 2003
Stock Commentary - Tokyo
17 November 2003
Tokyo pharma stocks - week to Nov 10
17 November 2003
Roche licenses Sankyo's CS-023
17 November 2003
Aventis' Ketek cleared in Japan for CARTIs
27 October 2003
Tokyo pharma stocks - week to Oct 13
20 October 2003
Stock Commentary - Tokyo
13 October 2003
Novartis and Sankyo enter collaboration
13 October 2003
Tokyo pharma stocks - week to Sept 29
13 October 2003
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
